Articles

Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia

Cancer Theme, SAHMRI, Division of Haematology, SA Pathology, University of Adelaide, South Australia, Australia
McGill University Health Centre, Montreal, QC, Canada
Hôpital Mignot, Université Versailles Saint-Quentin-en-Yvelines, Le Chesnay, France
City of Hope, Duarte, CA, USA
Service d’Hématologie Adulte, Hôpital Saint-Louis, Paris, France
UCSF School of Medicine, San Francisco, CA, USA
Bristol-Myers Squibb, Princeton, NJ, USA
Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy
Hematology/Oncology, Universitätsklinikum Jena, Germany
Princess Margaret Cancer Centre, Toronto, ON, Canada
University of Texas MD Anderson Cancer Center, Houston, TX, USA
Vol. 104 No. 1 (2019): January, 2019 https://doi.org/10.3324/haematol.2018.188987